| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015295A2 Radiopharmaceuticals for imaging infection and inflammation |
| 04/16/1998 | WO1998015287A1 Vaccines |
| 04/16/1998 | WO1998015284A2 Mycosis vaccines |
| 04/16/1998 | WO1998015178A1 Sordarin derivatives |
| 04/16/1998 | WO1998011229A3 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 04/16/1998 | WO1998009970A3 Alkylated rapamycin derivatives |
| 04/16/1998 | DE19640791A1 Glycokonjugate als Inhibitoren der viralen Zelladhäsion Glycoconjugates as inhibitors of viral cell adhesion |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268283A1 Attenuated microorganism strains expressing hpv proteins |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267767A1 Radiopharmaceuticals for imaging infection and inflammation |
| 04/16/1998 | CA2267191A1 Vaccines |
| 04/16/1998 | CA2255939A1 Herpes simplex virus strains |
| 04/15/1998 | EP0835938A2 Topoisomerase I |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835933A2 A G-protein coupled receptor, HLTEX11 |
| 04/15/1998 | EP0835930A1 European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV) |
| 04/15/1998 | EP0835929A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 04/15/1998 | EP0835928A1 Helicobacter pylori live vaccine |
| 04/15/1998 | EP0835880A1 Process for producing an IgM preparation for intravenous administration |
| 04/15/1998 | EP0835663A2 Combined vaccines comprising Hepatitis B surface antigen and other antigens |
| 04/15/1998 | EP0835318A2 Vaccines against hepatitis c |
| 04/15/1998 | EP0835315A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/15/1998 | EP0835313A1 Omp26 antigen from haemophilus influenzae |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835309A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835266A1 Modified/chimeric superantigens and their use |
| 04/15/1998 | EP0835258A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 04/15/1998 | EP0835252A1 Triazole antifungal agents |
| 04/15/1998 | EP0835133A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 04/15/1998 | EP0835132A1 Novel recombinant temperature sensitive mutants of influenza |
| 04/15/1998 | EP0835131A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86 |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835124A1 Serum preparations for inhibiting retroviruses and tumor growth |
| 04/15/1998 | EP0801655B1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 04/15/1998 | EP0711275B1 (thio)carbimidinic acid derivatives and medicaments containing the same |
| 04/15/1998 | EP0666749B1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 04/15/1998 | EP0550532B1 Dextrin sulfates as anti hiv-1 agents and composition thereof |
| 04/15/1998 | CN1179159A Guanine derivatives |
| 04/15/1998 | CN1179104A Method of treating or preventing non-viral microbial infection |
| 04/15/1998 | CN1179100A Valaciclovir bablets containing colloidal silicon dioxide |
| 04/15/1998 | CN1178789A Xanthene and arcridine derivative and its use |
| 04/15/1998 | CN1178701A Oral liquid curing AIDS and its preparing method |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/14/1998 | US5739339 Bactericides, antiprotozoa agents |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
| 04/14/1998 | US5739282 Amino acid sequence and dna |
| 04/14/1998 | US5739160 Cyclopentane- and -pentene-β-amino acids |
| 04/14/1998 | US5739141 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739120 Treatment of viral infections by administration of α- 1-(3-alkylthio-3-deoxy-2-O-acylglyceryl)!-ω 5'-(9-arabinosylpurinyl)! diphosphates or purine isosters thereof |
| 04/14/1998 | US5739118 Compositions and methods for delivery of genetic material |
| 04/14/1998 | US5739104 Anti-fungal agents |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739013 Enzymatic synthesis of 2',5'-oligoadenylate-2',3'-cyclophosphates and treatment of papillomaviruses |
| 04/14/1998 | US5739002 Providing reaction mixture comprising ns3 protease and substrate, adding candidate compound comprising fragment of hepatitis c virus ns4a protein, measuring protease activity to determine whether increase has occurred |
| 04/14/1998 | US5738985 Screening for potential antiviral agent by determining whether a potential antiviral agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus rna |
| 04/14/1998 | CA1339818C Antiviral purine derivatives |
| 04/09/1998 | WO1998014598A1 INTERLEUKIN-1β CONVERTING ENZYME LIKE CYSTEINE PROTEASE |
| 04/09/1998 | WO1998014586A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | WO1998014584A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | WO1998014564A1 Synthetic hpv16 virus-like particles |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014446A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014445A2 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | WO1998014436A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | WO1998014424A1 Hydroxamic acid derivatives |
| 04/09/1998 | WO1998014215A2 Glycoconjugates as virus cell adhesion inhibitors |
| 04/09/1998 | WO1998014212A1 Method of producing active immunity with vaccine conjugate |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014201A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | WO1998014199A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | WO1998014190A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | WO1998014189A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | WO1998002547A3 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 04/09/1998 | WO1998001546A3 Polyketides and their synthesis |
| 04/09/1998 | CA2268953A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 04/09/1998 | CA2268114A1 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2267683A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | CA2267645A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267415A1 Hydroxamic acid derivatives |
| 04/09/1998 | CA2267412A1 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/09/1998 | CA2267305A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | CA2267248A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | CA2265558A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834507A1 Substituted diamino-1,3,5-triazine derivatives |
| 04/08/1998 | EP0834322A2 Mycosis vaccine |